BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18620496)

  • 1. Quantification of simian immunodeficiency virus cytotoxic T lymphocyte escape mutant viruses.
    Loh L; Kent SJ
    AIDS Res Hum Retroviruses; 2008 Aug; 24(8):1067-72. PubMed ID: 18620496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques.
    Loh L; Batten CJ; Petravic J; Davenport MP; Kent SJ
    J Virol; 2007 May; 81(10):5418-22. PubMed ID: 17344299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination and timing influence SIV immune escape viral dynamics in vivo.
    Loh L; Petravic J; Batten CJ; Davenport MP; Kent SJ
    PLoS Pathog; 2008 Jan; 4(1):e12. PubMed ID: 18225952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection.
    Gooneratne SL; Alinejad-Rokny H; Ebrahimi D; Bohn PS; Wiseman RW; O'Connor DH; Davenport MP; Kent SJ
    J Virol; 2014 Dec; 88(24):14310-25. PubMed ID: 25275134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pigtail macaque MHC class I allele Mane-A*10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversion.
    Smith MZ; Fernandez CS; Chung A; Dale CJ; De Rose R; Lin J; Brooks AG; Krebs KC; Watkins DI; O'Connor DH; Davenport MP; Kent SJ
    J Med Primatol; 2005 Oct; 34(5-6):282-93. PubMed ID: 16128923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential patterns of immune escape at Tat-specific cytotoxic T cell epitopes in pigtail macaques.
    Mason RD; De Rose R; Kent SJ
    Virology; 2009 Jun; 388(2):315-23. PubMed ID: 19394064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost.
    Fernandez CS; Stratov I; De Rose R; Walsh K; Dale CJ; Smith MZ; Agy MB; Hu SL; Krebs K; Watkins DI; O'connor DH; Davenport MP; Kent SJ
    J Virol; 2005 May; 79(9):5721-31. PubMed ID: 15827187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.
    Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T
    J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques.
    Reece JC; Alcantara S; Gooneratne S; Jegaskanda S; Amaresena T; Fernandez CS; Laurie K; Hurt A; O'Connor SL; Harris M; Petravic J; Martyushev A; Grimm A; Davenport MP; Stambas J; De Rose R; Kent SJ
    J Virol; 2013 Apr; 87(8):4146-60. PubMed ID: 23345519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
    Friedrich TC; Dodds EJ; Yant LJ; Vojnov L; Rudersdorf R; Cullen C; Evans DT; Desrosiers RC; Mothé BR; Sidney J; Sette A; Kunstman K; Wolinsky S; Piatak M; Lifson J; Hughes AL; Wilson N; O'Connor DH; Watkins DI
    Nat Med; 2004 Mar; 10(3):275-81. PubMed ID: 14966520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts.
    Friedrich TC; McDermott AB; Reynolds MR; Piaskowski S; Fuenger S; De Souza IP; Rudersdorf R; Cullen C; Yant LJ; Vojnov L; Stephany J; Martin S; O'Connor DH; Wilson N; Watkins DI
    J Virol; 2004 Sep; 78(18):10064-73. PubMed ID: 15331739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity of the inoculum determines the rate of reversion of SIV Gag CD8 T cell mutant virus and outcome of infection.
    Loh L; Reece JC; Fernandez CS; Alcantara S; Center R; Howard J; Purcell DF; Balamurali M; Petravic J; Davenport MP; Kent SJ
    PLoS Pathog; 2009 Apr; 5(4):e1000378. PubMed ID: 19360124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-induced T cells control reversion of AIDS virus immune escape mutants.
    Fernandez CS; Smith MZ; Batten CJ; De Rose R; Reece JC; Rollman E; Venturi V; Davenport MP; Kent SJ
    J Virol; 2007 Apr; 81(8):4137-44. PubMed ID: 17251297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.
    O'Connor DH; Allen TM; Vogel TU; Jing P; DeSouza IP; Dodds E; Dunphy EJ; Melsaether C; Mothé B; Yamamoto H; Horton H; Wilson N; Hughes AL; Watkins DI
    Nat Med; 2002 May; 8(5):493-9. PubMed ID: 11984594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of molecular beacons for rapid, real-time, quantitative monitoring of cytotoxic T-lymphocyte epitope mutations in simian immunodeficiency virus.
    Peyerl FW; Barouch DH; Bazick HS; Manuel E; Letvin NL
    J Clin Microbiol; 2005 Sep; 43(9):4773-9. PubMed ID: 16145140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does cytolysis by CD8+ T cells drive immune escape in HIV infection?
    Balamurali M; Petravic J; Loh L; Alcantara S; Kent SJ; Davenport MP
    J Immunol; 2010 Nov; 185(9):5093-101. PubMed ID: 20881189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.
    Barouch DH; Powers J; Truitt DM; Kishko MG; Arthur JC; Peyerl FW; Kuroda MJ; Gorgone DA; Lifton MA; Lord CI; Hirsch VM; Montefiori DC; Carville A; Mansfield KG; Kunstman KJ; Wolinsky SM; Letvin NL
    Nat Immunol; 2005 Mar; 6(3):247-52. PubMed ID: 15685174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of simian immunodeficiency virus carrying multiple cytotoxic T-lymphocyte escape mutations with diminished replicative ability can result in AIDS progression in rhesus macaques.
    Seki S; Kawada M; Takeda A; Igarashi H; Sata T; Matano T
    J Virol; 2008 May; 82(10):5093-8. PubMed ID: 18337572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
    Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
    Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.